e-learning
resources
Copenhagen 2005
Monday 19.09.2005
Asthma and COPD: management and burden
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Projections of future costs of asthma and COPD in the Netherlands
M. Hoogendoorn, T. L. Feenstra, M. P. Rutten-van Mölken (Rotterdam, Bilthoven, Netherlands)
Source:
Annual Congress 2005 - Asthma and COPD: management and burden
Session:
Asthma and COPD: management and burden
Session type:
Thematic Poster Session
Number:
2465
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Hoogendoorn, T. L. Feenstra, M. P. Rutten-van Mölken (Rotterdam, Bilthoven, Netherlands). Projections of future costs of asthma and COPD in the Netherlands. Eur Respir J 2005; 26: Suppl. 49, 2465
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Costs of COPD and asthma in Sweden
Source: Eur Respir J 2004; 24: Suppl. 48, 701s
Year: 2004
Lifetime costs of COPD in the Netherlands
Source: Eur Respir J 2002; 20: Suppl. 38, 124s
Year: 2002
Costs of COPD exacerbations in a general population.
Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs
Year: 2018
Health care utilization and costs of asthma and COPD in the Netherlands
Source: Eur Respir J 2005; 26: Suppl. 49, 383s
Year: 2005
The costs of exacerbations in COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 273s
Year: 2001
Is there a need for pharmacoepidemiology in asthma and COPD?
Source: Annual Congress 2004 - Pharmacoepidemiology of obstructive lung disease: beyond clinical trials
Year: 2004
Cost and effectiveness of 2 years integrated care intervention in COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Costs of exacerbations in COPD
Source: Annual Congress 2012 - Healthcare utilisation and treatment of asthma and COPD
Year: 2012
Annual direct-cost of asthma and COPD in Turkey
Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management
Year: 2012
Current and future costs of COPD in the Netherlands
Source: Annual Congress 2013 –Health economics of airway diseases
Year: 2013
Societal costs of severe asthma in Sweden
Source: International Congress 2018 – Epidemiology of asthma and allergy: prevalence, incidence and risk factors
Year: 2018
Cost of asthma in patients treated with national asthma guideline in Turkey
Source: Eur Respir J 2003; 22: Suppl. 45, 481s
Year: 2003
Manner of treatment and costs of COPD exacerbations in secondary medical care in Poland
Source: Eur Respir J 2007; 30: Suppl. 51, 194s
Year: 2007
Hospital readmissions and social deprivation in asthma and COPD
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013
Exacerbations and healthcare resource utilization among COPD patients in Sweden
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
The healthcare burden of non-compliance to pharmacotherapeutic escalation recommendations for COPD
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016
The impact of implementing a COPD care bundle on the delivery of care to patients admitted with an acute exacerbation of COPD
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept